RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q4 2022 Q3 2022
Period Ending Sep 30, 2023 Dec 31, 2022 Sep 30, 2022
Net Income
-18.19M -14.7M -20.45M
Depreciation & Amortization
500K 419K 404K
Stock-Based Compensation
2.56M 2.11M 1.45M
Other Working Capital
67K 2.2M -296K
Other Non-Cash Items
66K 81K 6.64M
Deferred Income Tax
-2.27M -890K 23K
Change in Working Capital
67K 2.2M -296K
Operating Cash Flow
-17.26M -10.79M -12.23M
Capital Expenditures
-13.52M -2.81M -2.6M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-117.01M -96.89M -32.85M
Sales Maturities Of Investments
55M 24.41M 41.96M
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-75.54M -75.28M 6.5M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a -31K -12K
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
311.55M -352K 159.68M
Financial Cash Flow
311.55M -352K 159.68M
Net Cash Flow
218.75M -86.43M 153.95M
Free Cash Flow
-30.79M -13.59M -14.83M